The company asked to continue to do a good job in the prevention and control of the new coronary pneumonia epidemic.
Release time:
2021-01-11
war "epidemic" has not yet been successfully prevented and controlled still need to work
company requirements to continue to do a good job in the prevention and control of the new coronary pneumonia epidemic
this newspaper company recently issued a notice, requiring all units to continue to do a good job in the prevention and control of the new coronary pneumonia epidemic.
The recent global neo-coronary pneumonia epidemic has mutated, and local cases and asymptomatic infections have been found in many parts of the country, making the epidemic prevention and control situation more complex. As the Spring Festival approaches, people move and gather more frequently around the country, bringing many uncertainties to the prevention and control of the epidemic. To this end, the central and local party committees and governments at all levels have held special meetings to make arrangements for the prevention and control of the recent new coronary pneumonia epidemic. In order to fully and effectively implement the spirit of the superior's instructions on epidemic prevention and control, effectively do a good job in the company's epidemic prevention and control work, and ensure the health and safety of employees, the company specially puts forward requirements on relevant precautions:
Keep in mind the main responsibility and implement the prevention and control requirements. All units should fully understand the complexity of the current epidemic prevention and control situation, assume the main responsibility for epidemic prevention and control, and conscientiously and strictly implement various prevention and control measures in accordance with the requirements of the epidemic prevention and control responsibility letter, in line with the sense of responsibility for the life and health of employees, the enterprise and the society and the overall situation.
Strengthen workplace access and employee health management. Continue to do a good job in the temperature measurement and registration of employees entering the company at work. Foreign staff shall strictly measure the temperature, check the health code and register. If symptoms such as fever, cough and chest tightness are found, they shall be advised to seek medical treatment in time. Express delivery and take-out personnel are not allowed to enter the office and production areas.
Strengthen staff health education and develop good health and epidemic prevention habits. Strengthen the publicity of health and epidemic prevention knowledge, and educate employees on epidemic prevention and control; advocate scientific wearing of masks, sorting and putting of garbage, timely disinfection of foreign items, avoiding going to crowded places, maintaining a safe social distance, washing hands frequently, frequent ventilation and other work and living habits.
Strengthen the internal public health work of the company, and do a good job in the production sites and public places of the enterprise.
Strictly enforce food hygiene regulations to eliminate food safety hazards. Strengthen the management of canteen procurement, cleaning and processing, and cooking; Strictly disinfect the canteen environment and tableware; Continue to implement the system of dividing meals by time, and remind employees to keep a certain safe distance when eating in the canteen.
Reasonable arrangements for travel, orderly control of personnel flow. Strengthen mission work and avoid travel to medium-high risk areas. Employees who must travel to medium and high-risk areas due to work relations or work abroad in relevant areas must strictly carry out nucleic acid tests after returning to the unit, and the test results are normal before going to work. The nucleic acid test expenses shall be reimbursed by the unit to which they belong.
Reduce all kinds of activities and reduce personnel gathering. Reasonably arrange all kinds of meetings at the end of the year and the beginning of the year, and organize them online or video as much as possible; Cancel unnecessary dinners and parties, and strictly control the scale of various activities.
In addition to continuously and conscientiously implementing the internal epidemic prevention and control requirements of the enterprise, in view of the frequent movement of personnel and the increase in the number of gatherings of relatives and friends before and after the Spring Festival, the company also specially advocated in the notice that employees should stay in the place where the unit is located for the holidays, reduce going out, adopt WeChat, video and other online New Year greetings as far as possible, avoid gatherings in crowded and poorly ventilated places, and prevent the epidemic risks as possible, it is hoped that employees will pay attention to the epidemic information through authoritative channels, resolutely resist all kinds of online rumors, do not spread rumors, do not believe rumors, do not spread rumors, and all employees will work together to do a good job in the company's epidemic prevention and control work. (this newspaper reporter)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page